Overview
Description
OPERATING GLOBALLY
Turnover in excess of £146,000.
Identifies biologically active components in venoms to develop novel pharmaceuticals and biopesticides.
Is a global leader in venom research.
Shareholders are supported by a team of dedicated and knowledgeable employees with years of experience and advanced academic qualifications.
Key Shareholders have offered a negotiable handover period, or to retain their roles within the company.
Operates from leasehold premises in a science park.
Offered for sale to facilitate growth under the impetus of new ownership.
Offers invited.
Is this business relocatable:
Is stock included:
Listed By:
Similar Listings
The company is a provider of building energy management systems and HVAC control solutions, catering to commercial, industrial, and public sector clients, having been incorporated since 1993. The business’s strong reputation is built on a proven tr...
The company supplies copper and fibre optic cable infrastructure systems and audio/visual products and services. Over its decades of operation, the company has established a number of strong relationships with prestigious clients operating across the...
The company is an industry-leading specialist provider of reuse and recycling services for redundant IT technology. The business has obtained extensive contacts and marketing leading experience of trading, exporting, and brokering IT scrap from other...
Overview Offered for sale is a medical specialist providing equipment in a niche market with the potential to supply existing products into other markets. The company works with local authorities, the NHS, and public sector organisations to provide ...
This is a superb opportunity to acquire a well-established ironing business based in South Leicestershire. The business is available on a relocatable basis. The business operates as a small family run, reputable ironing business and offer their servi...
Achieved turnover of circa £700k in YE23. The business has £3m of secured work in the pipeline. £13 million of investment in the technology portfolio through acquisition and organic growth. The company has organically designed and developed an i...